Skip to content
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which […]
Key takeaways from the State of the Union address Read More »
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear Read More »
Bipartisan legislation to support research into rare diseases received backing from witnesses and lawmakers during a Feb. 29 hearing of the House Energy and
Lawmakers back bipartisan legislation supporting rare disease research Read More »
Biotechnology Innovation Organization (BIO) member companies and CEOs sent a letter to congressional leaders urging them to pass the bipartisan ORPHAN Cures Act and
CEOs ask Congress to pass ORPHAN Cures Act Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
Rare Disease Week 2024, taking place February 25–28, is an important annual reminder of the need to find cures and improve therapies for patients.
Rare Disease Week 2024: standing up for 1 in 10 Americans Read More »
Agricultural productivity has been failing to meet the targets necessary to feed the world’s growing population, says the latest Global Agricultural Productivity (GAP) report.
Agricultural productivity lags, 2023 GAP report shows Read More »
Before heading home for President’s Day recess, Members of Congress made progress on a few priorities for the biotech industry. Of note, the House
House introduces bill to reauthorize PPRV Read More »
Encouraging farmers to use biotech and other climate tech to make agriculture more sustainable requires ensuring that their impact on climate is measured accurately
USDA forum puts focus on biotech for sustainable farming Read More »
GSK believes that “innovation starts when we stop to listen.” In 2023, GSK took a moment to engage with a variety of people across
GSK survey shows optimism for the future of biotech innovation Read More »
